TMS vs ECT: Differences, Benefits, Risks & Treatment Options

Transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT) are both brain-stimulation treatments used when depression or other serious psychiatric symptoms have not improved enough with standard treatment. However, they differ significantly in how they work, how quickly they may help, their side effects, and the level of medical support required. TMS is a noninvasive outpatient treatment that uses magnetic stimulation and typically does not require anesthesia, while ECT uses a controlled electrical stimulus under general anesthesia to produce a brief therapeutic seizure. This comprehensive guide explains the differences between TMS and ECT, including effectiveness, memory effects, treatment schedules, safety, bipolar depression considerations, and questions patients should discuss with their psychiatrist before deciding which treatment may be appropriate.

---

Brain Stimulation Therapy • Psychoeducation • Treatment Comparison • Decision Support

TMS and ECT: Understanding the Differences

A comprehensive guide to transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), including how each treatment works, when each may be considered, differences in effectiveness, side effects, memory effects, anesthesia, treatment schedules, bipolar-depression considerations, and questions to discuss with a psychiatrist.

Mark Zauss, BC-TMC, LMHC, LPC, CCMHC, NCC, ASDCS, CCTP, CCTP II, NATC, ADHD-CCSP, C-DBT, C-PD
For psychoeducation and collaborative treatment planning. This worksheet does not determine medical eligibility for TMS or ECT and does not replace evaluation by a psychiatrist or other appropriately trained physician.

Print / Save PDF Download Worksheet Notes

What are TMS and ECT?

TMS — Transcranial Magnetic Stimulation

TMS is a noninvasive brain-stimulation treatment that uses rapidly changing magnetic fields to induce small electrical currents in targeted brain regions. The patient remains awake, no seizure is intentionally produced, and general anesthesia is not normally required.

Repetitive TMS (rTMS), including newer patterned approaches such as theta-burst stimulation, is most commonly used for treatment-resistant major depression. Specific FDA-cleared devices/protocols are also used for obsessive-compulsive disorder, migraine, smoking cessation, and certain depressive presentations with anxiety.

ECT — Electroconvulsive Therapy

ECT is a medical procedure performed under general anesthesia with a muscle relaxant. A carefully controlled electrical stimulus intentionally produces a brief therapeutic seizure. Modern ECT is substantially different from historical portrayals and is performed with physiologic monitoring and individualized dosing.

ECT is particularly important for severe or treatment-resistant depression, severe bipolar depressive episodes, catatonia, and situations requiring a rapid response, such as severe suicidality, inability to eat or drink, or profound functional deterioration.

Illustration 1. TMS stimulates selected cortical networks magnetically without intentionally causing a seizure; ECT uses anesthesia and a controlled electrical stimulus to produce a therapeutic seizure.

Quick comparison: TMS vs ECT

Feature	TMS	ECT
Type of stimulation	Magnetic field induces localized electrical activity.	Electrical stimulus intentionally induces a brief seizure.
Anesthesia	Usually none.	Short-acting general anesthesia plus muscle relaxant.
Patient awake?	Yes.	No, during the procedure.
Typical treatment frequency	Often 5 days/week for approximately 4–6 weeks; protocol varies. Accelerated protocols may deliver multiple treatments per day.	Often about 3 treatments/week during an acute series, commonly around 6–12 treatments; individualized maintenance may follow.
Speed of response	Often gradual over several weeks.	Can work rapidly; improvement may begin within the first week in some severe depressive episodes.
Relative antidepressant strength	Effective for many patients with treatment-resistant depression, but generally less powerful than ECT.	Among the most effective acute treatments for severe and treatment-resistant depression.
Memory effects	Clinically significant memory loss is not a typical adverse effect.	Temporary confusion and memory impairment can occur. Some patients experience gaps in autobiographical memory; risk varies with technique.
Common side effects	Scalp discomfort, headache, facial-muscle twitching; rare seizure risk.	Headache, nausea, muscle aches, transient confusion, memory problems; anesthesia-related risks.
Driving / work afterward	Many patients can resume usual activities immediately, depending on individual effects and clinic advice.	Driving restrictions and assistance are typically required during an acute course because of anesthesia and cognitive effects.
Best known role	Noninvasive option when depression has not sufficiently improved with medication/therapy or medication is poorly tolerated.	Severe, psychotic, catatonic, suicidal, treatment-resistant, or urgently disabling mood illness.

How TMS works

Targeted Stimulation

A coil placed against the scalp produces rapidly changing magnetic fields. These fields pass through the skull and influence electrical activity in targeted cortical networks, often including prefrontal areas involved in mood and cognitive control.

Repeated Network Effects

Repeated sessions are believed to alter network excitability and connectivity over time. TMS is not simply “turning on dopamine”; its effects involve broader changes in cortical and interconnected mood-regulation networks.

Different Protocols

Traditional rTMS, deep TMS, intermittent theta-burst stimulation, and accelerated approaches differ in coil design, pulse pattern, duration, and treatment schedule. FDA clearance applies to specific devices and protocols rather than to every form of TMS for every disorder.

How ECT works

Controlled Seizure

Under anesthesia, a carefully dosed electrical stimulus produces a brief generalized seizure. The seizure is monitored using EEG and physiologic measures.

Brain-Wide Biological Effects

ECT produces rapid changes across multiple neural systems, including mood-regulation circuits, neurochemical signaling, network connectivity, and neuroplastic processes. Its exact antidepressant mechanism is not reducible to one neurotransmitter.

Technique Matters

Electrode placement and pulse width influence both effectiveness and cognitive side effects. Right-unilateral and ultrabrief-pulse approaches may reduce memory effects for some patients compared with traditional bilateral treatment, although technique is individualized.

When TMS may be considered

Depression has not responded sufficiently to one or more adequate medication trials. Medication side effects make continued pharmacologic treatment difficult. The patient prefers a noninvasive treatment without general anesthesia. The patient can attend frequent outpatient treatment sessions. There is no immediate clinical need for the fastest possible antidepressant response. A psychiatrist believes an FDA-cleared TMS indication or evidence-supported off-label use is clinically appropriate.

When ECT may be considered

Severe or treatment-resistant major depression. Severe bipolar depressive episode. Psychotic depression. Catatonia. Severe suicidality or another condition requiring a rapid response. Severe malnutrition, dehydration, immobility, or inability to function because of psychiatric illness. Medications have failed, are contraindicated, or cannot be tolerated. ECT was previously effective or is preferred after informed discussion.

Bipolar disorder: ECT has an established role in severe bipolar depression and can also be used for mania in selected cases. TMS may sometimes be used clinically for bipolar depression, but FDA clearance depends on the specific device and indication; TMS should not be described as broadly FDA-approved for bipolar disorder. A psychiatrist should evaluate mood-switching risk, current mood state, medication coverage, and individual evidence before treatment.

Effectiveness: what patients should understand

Both treatments can be effective, but they occupy different places on the treatment-intensity spectrum. TMS offers a lower-burden outpatient approach with minimal cognitive disruption for many patients. ECT is usually the more powerful intervention when depression is very severe, psychotic, catatonic, life-threatening, or highly treatment resistant. NIMH describes ECT as the “gold standard” for treatment-resistant depression and notes that rTMS does not match ECT's therapeutic effect.

Illustration 2. Treatment selection depends on illness severity, urgency, prior treatment response, medical status, cognitive-risk concerns, patient preference, and clinician judgment.

Side effects and safety

TMS Side Effects

• Scalp discomfort or tenderness during stimulation
• Headache
• Tingling or facial-muscle twitching
• Temporary discomfort from coil noise; hearing protection is generally used
• Rare seizure risk
• Possible mood activation or hypomania/mania in susceptible individuals

TMS does not generally cause the same degree of memory impairment associated with ECT and does not normally require anesthesia.

ECT Side Effects

• Temporary confusion after treatment
• Headache, nausea, jaw discomfort, or muscle aches
• Anesthesia-related medical risks
• Short-term difficulty learning or remembering information around the treatment period
• Retrograde/autobiographical memory gaps in some patients

Memory effects vary substantially between patients and depend partly on electrode placement, pulse width, dose, treatment frequency, age, and individual vulnerability.

What about memory?

This is one of the most important differences between the treatments. TMS is not typically associated with clinically important memory loss. ECT can cause temporary confusion and memory difficulty, particularly for events occurring near the treatment course. Some individuals report more significant autobiographical memory gaps. Modern techniques—especially right-unilateral placement and shorter pulse widths in appropriate patients—may reduce cognitive burden compared with older bilateral approaches.

A useful question for the ECT psychiatrist: “What electrode placement and pulse width are you recommending for me, why, and how are you balancing antidepressant effectiveness against cognitive side effects?”

What happens during a TMS session?

1. Positioning

The patient sits awake in a treatment chair. A magnetic coil is positioned over a prescribed scalp location.

2. Stimulation

Magnetic pulses produce tapping sensations and clicking sounds. The patient can communicate throughout the procedure.

3. Return to Routine

There is normally no anesthesia recovery period. Many patients can drive themselves and return to usual activities, unless their clinician advises otherwise.

What happens during ECT?

1. Preparation

The patient undergoes medical evaluation, follows fasting instructions, receives an IV, and is monitored by the treatment team.

2. Anesthesia & Treatment

Short-acting general anesthesia and a muscle relaxant are given. Electrodes deliver a controlled electrical stimulus that produces a brief therapeutic seizure.

3. Recovery

The patient awakens shortly afterward and is monitored during recovery. Confusion, headache, nausea, or temporary memory difficulty may occur. Transportation and driving restrictions are generally required.

Comprehensive treatment-decision worksheet

This section is designed to organize questions for a treating psychiatrist. It is not a scoring test and should not be used to choose TMS or ECT without medical evaluation.

Primary diagnosis or diagnoses being treated: How severe are the current symptoms, and how are they affecting safety, nutrition, sleep, work, relationships, or basic functioning? What medications have been tried? Include dose, duration, benefit, and side effects when known. What psychotherapy or other treatments have been tried, and what was the response? Is there current suicidal risk, psychosis, catatonia, severe inability to eat/drink, or another reason a rapid response may be necessary? How important is avoiding memory/cognitive side effects? Could the patient realistically attend daily outpatient TMS for several weeks? Could the patient arrange transportation, anesthesia clearance, and post-treatment support for ECT? Is there a history of bipolar disorder, mania/hypomania, psychosis, seizures, neurological disease, implanted metal/electronic devices, significant cardiac disease, or anesthesia complications? What matters most to the patient: fastest possible response, avoiding anesthesia, minimizing cognitive effects, fewer clinic visits, prior treatment success, or another factor?

Questions to ask a TMS psychiatrist or clinic

What exact diagnosis and FDA-cleared or evidence-supported indication are you treating? Which device and protocol will be used? Traditional rTMS, deep TMS, theta-burst, or accelerated treatment? How is the treatment target determined? How many sessions are expected? How will response be measured? What happens if there is only partial improvement? Is a taper or maintenance treatment recommended? How do my current medications affect seizure threshold or treatment? If bipolar disorder is present, how will mood switching be monitored?

Questions to ask an ECT psychiatrist

Why are you recommending ECT at this point in treatment? Right unilateral, bifrontal, or bilateral placement—and why? Brief pulse or ultrabrief pulse? How many acute treatments are anticipated? How will memory and cognition be monitored? What is the expected response timeline? What medical/anesthesia clearance is needed? Which medications should be continued or held around treatment? Will continuation medication, maintenance ECT, or both be recommended afterward? What driving/work restrictions should be expected during the course?

Situations that can change the decision

Severe urgency

When a person is acutely suicidal, catatonic, severely psychotic, not eating or drinking, or otherwise medically endangered by psychiatric illness, the need for a rapid and highly effective response may favor ECT.

Cognitive vulnerability

When memory preservation is a particularly high priority and the clinical situation does not require ECT's speed or intensity, TMS may be attractive because significant cognitive adverse effects are uncommon.

Medical/anesthesia concerns

TMS generally avoids anesthesia. ECT requires evaluation of anesthesia and cardiovascular risk, although it is routinely performed in medically complex and older adults when appropriately assessed.

Previous response

A prior strong response to TMS or ECT is highly relevant. Maintenance strategies may be considered because improvement can relapse after either treatment if follow-up care is insufficient.

Neither treatment is usually “stand-alone” care

Brain stimulation is often integrated with medication, psychotherapy, sleep treatment, behavioral activation, social support, relapse-prevention planning, and management of co-occurring conditions. Improvement after TMS or ECT does not necessarily mean other treatment should be stopped. Maintenance treatment is particularly important after successful ECT because relapse can occur without continuation therapy.

Medication changes: Patients should not independently stop antidepressants, mood stabilizers, benzodiazepines, stimulants, anticonvulsants, or other psychiatric medications before TMS or ECT. Some medications may affect seizure threshold, anesthesia, or treatment response, so changes should be directed by the treating medical team.

When urgent psychiatric care is needed

Urgent evaluation is appropriate for suicidal intent, inability to remain safe, severe psychosis, catatonia, refusal or inability to eat/drink, rapidly worsening mania, dangerous impulsivity, or severe inability to care for basic needs. In the United States, call or text 988 for the Suicide & Crisis Lifeline; call 911 or go to an emergency department for an immediate life-threatening emergency.

Clinical resources & references (APA style)

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing.
2. American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder. American Psychiatric Association Publishing.
3. National Institute of Mental Health. (n.d.). Brain stimulation therapies. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
4. National Institute of Mental Health. (n.d.). Depression. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/depression
5. National Institute for Health and Care Excellence. (2022, updated). Depression in adults: Treatment and management (NICE Guideline NG222). https://www.nice.org.uk/guidance/ng222
6. Mayo Clinic. (2023). Electroconvulsive therapy (ECT). https://www.mayoclinic.org/tests-procedures/electroconvulsive-therapy/about/pac-20393894
7. Mayo Clinic. (n.d.). Transcranial magnetic stimulation. https://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/about/pac-20384625
8. Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation, 9(3), 336–346. https://doi.org/10.1016/j.brs.2016.03.010
9. Rasmussen, K. G. (Ed.). (2019). Principles and practice of electroconvulsive therapy. American Psychiatric Association Publishing.

Mark Zauss, BC-TMC, LMHC, LPC, CCMHC, NCC, ASDCS, CCTP, CCTP II, NATC, ADHD-CCSP, C-DBT, C-PD
This resource is intended for psychoeducation and collaborative treatment planning. It does not establish candidacy for TMS or ECT and should be used alongside evaluation by a qualified psychiatrist and medical team.